5Wolf P. The nature and significance of platelet products in human plasma. Br J Haemat, 1967,13: 269-286.
6Sandberg H, Bode AP, Dombrose FA, et al. Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and factor 3. Thromb Res, 1985, 39: 63-79.
7Zwaal RF, Bevers EM, Comfurius P, et al. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem, 1989, 91: 23-31.
8Tans G, Rosing J, Thomassen MC, et al. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood, 1991, 77: 2641-2648.
9Nieuwland R, Berckmans RJ, Eijkman RCR, et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation, 1997, 96: 3534- 3541.
10George JN, Peckett EB, Sauceman S, et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest, 1986, 78: 340-348.
